Clinical Trial Update: Effect of High-Dose NAC on Patients With DPN [Phase 4]

View source ↗

Summary

A Phase 4 clinical trial update studying the effect of high-dose N-acetylcysteine (NAC) on patients with diabetic neuropathies; current status is UNKNOWN.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Diabetic Neuropathy

Drugs mentioned

• N-acetylcysteine (N-acetylcysteine)

Snippet

Sponsor: Ain Shams University | Conditions: Diabetic Neuropathies | Phase 4 | Status: UNKNOWN